Truist Financial

Company

Last mentioned: Feb 19, 2026

Stories mentioning Truist Financial 2

Waystar Valuation Rift: Needham Slashes Target to $33 as Truist Holds $38 Bull Case

Waystar (NASDAQ: WAY) is navigating a divided Wall Street as Needham & Company lowered its price target to $33.00, citing potential growth headwinds. This move contrasts with Truist Financial's $38.00 valuation, highlighting a widening gap in expectations for the healthcare payment platform's market penetration.

Feb 19, 2026 3 sources

market-trends Neutral

Waystar Analyst Outlook: Needham Cuts Target to $33, Truist Sets $38

Waystar (NASDAQ: WAY) is facing a divergent outlook from major analysts as Needham & Company LLC lowered its price target to $33.00, while Truist Financial established a more optimistic $38.00 target. These updates come as the healthcare payments SaaS provider navigates a complex post-IPO landscape characterized by shifting provider spending patterns.

Feb 19, 2026 3 sources